This image is not available for purchase in your country.

Herceptin breast cancer drug molecule

Herceptin breast cancer drug molecule

A617/0260

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

EQUINOX GRAPHICS / SCIENCE PHOTO LIBRARY EQUINOX GRAPHICS / SCIENCE PHOTO LIBRARY

Caption

Herceptin breast cancer drug, molecular model. Herceptin (Trastuzumab) is a monoclonal antibody that binds to the HER2 receptor (human epidermal growth factor receptor 2) on breast cancer cells, causing them to die during their reproductive cycle. Around a fifth of breast cancers are made up of cells that over-express this receptor, making them viable for Herceptin treatment. In this model the molecule's shape (secondary structure) is seen, comprising alpha helices (coils), beta sheets (arrows) and linking regions (lines).

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}